U.S. spot crypto ETF flows, all-time high stablecoin supply, prediction markets going mainstream, a perp DEX resurgence, and the DAT craze were among the most notable data trends of the year.
Delivery fails involving 10-year Treasury notes surged to the highest level in eight years this month, a result of the Federal Reserve’s move to shrink its bond portfolio since 2022. Trades involving ...
Mark Dubois, natural resource manager for Poland Spring, checks out Cold Spring in Denmark, Maine, in December 2022. Since August, Maine has faced a persistent drought. Rivers and streams are running ...
Wall Street broker Benchmark said bitcoin miner Hut 8 (HUT) is using last week’s River Bend announcement to cement a shift from a crypto-first power owner into an institutional-grade digital ...
South Korea’s robust semiconductor exports continued to mask weakness in other sectors, helping maintain growth in the overall value of shipments in the first weeks of December, as the nation weathers ...
If you’re going online to buy some last-minute gifts this holiday season, there’s a chance the price you pay will be influenced by what’s known as “surveillance pricing.” Some retailers are using ...
Memory-chip maker Micron Technology reported blockbuster earnings this past week, easily exceeding expectations for its latest quarter and offering outstanding guidance for the current one as well.
Alexandria Ocasio-Cortez is incorporating Gen Z messaging and viral jabs at Vice President J.D. Vance into her playbook as she builds momentum for a 2028 presidential run, a Republican political ...
California Gov. Gavin Newsom has launched a state-run website that catalogues criminal convictions and clemency grants tied to President Donald Trump, escalating a digital political feud by using ...
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results